SOX2 and glioma: Besides, SOX2+ tumor cells were enriched in gliomas that could relapse following radiation therapy or chemotherapy with TMZ, and it was evinced that glioma cell population with CD133+ (an important marker for GSC) had higher levels of SOX2 expression (Bao et al., 2006; Auffinger et al., 2015).